Tirzepatide is a GLP-1 receptor agonist that has the advantage in clinical trials of superior performance over other GLP-1 medications showing up to a 25% increase in body weight reduction, surpassing many other weight loss medications.  Tirzepatide targets both GIP and GLP-1 receptors, enhancing insulin secretion, reducing appetite, and improving energy balance more effectively than single receptor agonists.

It promotes fat loss while preserving lean muscle mass, which is crucial for long-term metabolic health.  It has been shown to cause less side effects than its counterparts including less nausea and lower dosing for effectiveness.

Yearly labs required (your lab or mine/within the last year) and Weight Loss labs preferred.

Let’s talk about your plans for diet and exercise – we have helpful recommendations!